The move to support waiving intellectual property protections on vaccines under World Trade Organization rules marked a dramatic shift for the United States — and drew cheers from activists, complaints from Big Pharma, and a lot of questions about what comes next.
According to the Department of Health and Human Services, a woman in her 80s with underlying medical conditions developed COVID-19 and was hospitalized more than 14 days after completing a vaccination series with the Pfizer vaccine.
The U.S. Food and Drug Administration is expected to authorize Pfizer’s COVID-19 vaccine for young adults age 12 and older by next week, setting up shots for many before the beginning of the next school year.
Thousands of restaurants and bars decimated by the COVID-19 outbreak have a better chance at survival as the government begins handing out $28.6 billion in grants — money to help these small businesses stay afloat while they wait for customers to return.
Two White House officials say the U.S. trade representative will begin talks in the World Trade Organization on ways to overcome intellectual property issues that are keeping poorer countries from making their own generic version of critically needed COVID-19 vaccines.
A fire in a COVID-19 hospital ward in western India has killed 18 patients as the country grappling with the worst outbreak yet steps up a vaccination drive for all its adults even though some states say don’t have enough jabs.